Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118836452 | 11883645 | 2 | F | 20151029 | 20160610 | 20160101 | 20160920 | PER | US-ASTRAZENECA-2015SF06025 | ASTRAZENECA | 27863.00 | DY | M | Y | 104.30000 | KG | 20160921 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118836452 | 11883645 | 1 | PS | BYDUREON | EXENATIDE | 1 | Unknown | FK0003 | 22200 | 2 | MG | /wk | |||||||
| 118836452 | 11883645 | 2 | SS | BYDUREON | EXENATIDE | 1 | Unknown | FK0003 | 22200 | 2 | MG | /wk | |||||||
| 118836452 | 11883645 | 3 | SS | BYDUREON | EXENATIDE | 1 | Subcutaneous | BYDUREON KIT, 2 MG, ONCE A WEEK | 22200 | /wk | |||||||||
| 118836452 | 11883645 | 4 | SS | METOPROLOL. | METOPROLOL | 1 | Oral | U | 0 | 150 | MG | QD | |||||||
| 118836452 | 11883645 | 5 | C | GLIPIZIDE. | GLIPIZIDE | 1 | 10MG BID | 0 | |||||||||||
| 118836452 | 11883645 | 6 | C | GLIPIZIDE. | GLIPIZIDE | 1 | 10 MG, DAILY | 0 | |||||||||||
| 118836452 | 11883645 | 7 | C | HYDROCHOLORTHIAZIDE (HCTZ) | 2 | 0 | |||||||||||||
| 118836452 | 11883645 | 8 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 0 | 20 | MG | QD | |||||||||
| 118836452 | 11883645 | 9 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 0 | 10 | MG | QD | |||||||||
| 118836452 | 11883645 | 10 | C | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 118836452 | 11883645 | 11 | C | STATIN DRUG | 2 | 0 | |||||||||||||
| 118836452 | 11883645 | 12 | C | ASPIRIN. | ASPIRIN | 1 | DAILY | 0 | |||||||||||
| 118836452 | 11883645 | 13 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118836452 | 11883645 | 1 | Type 2 diabetes mellitus |
| 118836452 | 11883645 | 2 | Type 2 diabetes mellitus |
| 118836452 | 11883645 | 3 | Type 2 diabetes mellitus |
| 118836452 | 11883645 | 4 | Cardiac disorder |
| 118836452 | 11883645 | 5 | Type 2 diabetes mellitus |
| 118836452 | 11883645 | 6 | Type 2 diabetes mellitus |
| 118836452 | 11883645 | 7 | Blood pressure abnormal |
| 118836452 | 11883645 | 8 | Blood pressure abnormal |
| 118836452 | 11883645 | 9 | Blood pressure abnormal |
| 118836452 | 11883645 | 10 | Prostatic disorder |
| 118836452 | 11883645 | 11 | Blood cholesterol abnormal |
| 118836452 | 11883645 | 13 | Blood cholesterol increased |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118836452 | 11883645 | Body height decreased | |
| 118836452 | 11883645 | Drug dispensing error | |
| 118836452 | 11883645 | Injection site haemorrhage | |
| 118836452 | 11883645 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118836452 | 11883645 | 1 | 20151028 | 0 | ||
| 118836452 | 11883645 | 2 | 201603 | 0 | ||
| 118836452 | 11883645 | 3 | 20160610 | 0 |